Search
Lantern Pharma Inc
LTRNAdd to Watchlist
1.390USD
+0.030+2.21%
Close 09-22 16:00（ET）
17.74MMarket Cap
LossP/E TTM
Lantern Pharma Inc (LTRN) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Lantern Pharma Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.500USD+1186.76%
LTRN Analyst Recommendation Trends
In the current month, LTRN has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LTRN average Analyst price target in the last month is 17.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
Financial Forecasting
Based on analysts' estimates, LTRN EPS is projected to reach -0.350 in FY2026Q3, following reported EPS of -0.569 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.46
-0.36
-0.38
-0.35
-0.41
Actual
-0.36
-0.30
-0.57
--
--
Surprise
+20.84%
+17.82%
-49.81%
--
--
FAQs
What is Lantern Pharma Inc's price target?
Analysts forecast that Lantern Pharma Inc's price target is USD 20.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 15.00.
How have Lantern Pharma IncLTRN's recent earnings per share performed?
The market expectation was USD -0.57, while Lantern Pharma IncLTRN's earnings per share (EPS) for the previous quarter was USD -0.30. EPS for the next quarter is expected at USD -0.35.
What is the analyst rating for Lantern Pharma Inc?
Based on the ratings of Lantern Pharma Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.